Primary Retroperitoneal Mucinous Cystadenocarcinoma during Long-term Administration of Infliximab for the Treatment of Crohn's Disease.
Intern Med
; 62(24): 3619-3624, 2023 Dec 15.
Article
in En
| MEDLINE
| ID: mdl-37164674
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retroperitoneal Neoplasms
/
Crohn Disease
/
Cystadenocarcinoma, Mucinous
Limits:
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Intern Med
Journal subject:
MEDICINA INTERNA
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
Japan